Optiver Holding
AVBP icon

Optiver Holding’s ArriVent BioPharma AVBP Stock Holding History

Optiver Holding’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Sell
108
-150
-58% -$4.43K ﹤0.01% 2094
2026
Q1 		$5.95K Buy
258
+124
+93% +$2.8K ﹤0.01% 1356
2025
Q4 		$2.7K Sell
134
-172
-56% -$3.58K ﹤0.01% 1830
2025
Q3 		$5.65K Buy
+306
New +$6.01K ﹤0.01% 1642

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Optiver Holding's AVBP Position: Q2 2026 in Review

Optiver Holding reduced its ArriVent BioPharma (AVBP) stake by 58% in Q2 2026, selling an estimated $4.43K and leaving 108 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Optiver Holding first reported a position in AVBP in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.95K in Q1 2026. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Optiver Holding held 108 shares of ArriVent BioPharma worth $3.75K as of Q2 2026.
  • Optiver Holding sold 150 ArriVent BioPharma shares in Q2 2026, an estimated $4.43K.
  • ArriVent BioPharma made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2094 holding.
  • Optiver Holding first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's ArriVent BioPharma position peaked at $5.95K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.